title: Chemical modification of chalcone isomerase by diethyl pyrocarbonate: histidine residues are not essential for catalysis.
abstract: Chalcone isomerase form soybean is inactivated by treatment with diethyl pyrocarbonate (DEP). The competitive inhibitor 4',4-dihydroxychalcone provides kinetic protection against inactivation by DEP with a binding constant at the site of protection in agreement with its binding constant at the active site. Very high concentrations of the competitive inhibitors 4',4-dihydroxychalcone or morin hydrate offer a 10- to 40-fold maximal protection, suggesting a second slower mechanism for inactivation which cannot be prevented by blockage of the active site. Blockage of the only cysteine residue in chalcone isomerase with p-mercuribenzoate does not affect the rate constant for DEP-dependent inactivation and indicates that the modification of the cysteine residue is not responsible for the activity loss observed in the presence of DEP. Treatment of inactivated enzyme with hydroxylamine does not restore catalytic activity, indicating that the modification of histidine or tyrosine residues is not responsible for the activity loss. All five histidines of chalcone isomerase are modified by DEP at pH 5.7 and ionic strength 1.0 M. The rate constant for the modification of the histidine residues of chalcone isomerase is close to that for the reaction of N-acetyl histidine with DEP, indicating that the histidine residues are quite accessible to the modifying reagent. The rate of histidine modification is the same in native enzyme, in urea-denatured enzyme, and in the presence of a competitive inhibitor. In the presence of the competitive inhibitor morin hydrate, all of the histidine residues of chalcone isomerase can be modified without significant loss in catalytic activity. These results demonstrate that the histidine residues of chalcone isomerase are not essential for catalysis and therefore cannot function as nucleophilic catalysts as previously proposed.
authors.affiliation: Department of Pharmacological Sciences, State University of New York, Stony Brook 11794-8651.
authors.forename: R A
authors.initials: RA
authors.lastname: Bednar
authors.forename: A J
authors.initials: AJ
authors.lastname: Adeniran
mesh_terms: D001665:Binding Sites; D002384:Catalysis; D004047:Diethyl Pyrocarbonate / Q000494:pharmacology*; D006639:Histidine / Q000737:chemistry*; D019753:Intramolecular Lyases; D007535:Isomerases / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000378:metabolism; D007700:Kinetics; D013025:Glycine max
chemical_list: D006639:Histidine; D007535:Isomerases; D019753:Intramolecular Lyases; C019865:chalcone isomerase; D004047:Diethyl Pyrocarbonate